Moors & Cabot, Inc. Sanofi Transaction History

Moors & Cabot, Inc.

$1.85 Billion
Q2 2024

A detailed history of Moors & Cabot, Inc. transactions in Sanofi stock. As of the latest transaction made, Moors & Cabot, Inc. holds 8,288 shares of SNY stock, worth $477,803. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,288

Previous 7,262 14.13%

Holding current value

$477,803

Previous $352,000 14.2%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$45.39 - $50.36 $46,570 - $51,669	1,026 Added 14.13%	8,288 $402,000
Q1 2024 May 08, 2024	SELL	$45.75 - $52.48 $11,346 - $13,015	-248 Reduced 3.3%	7,262 $352,000
Q4 2023 Feb 14, 2024	BUY	$43.13 - $54.79 $51,540 - $65,474	1,195 Added 18.92%	7,510 $373,000
Q3 2023 Nov 07, 2023	BUY	$50.95 - $55.2 $42,950 - $46,533	843 Added 15.41%	6,315 $338,000
Q2 2023 Aug 09, 2023	SELL	$50.45 - $57.18 $118,607 - $134,430	-2,351 Reduced 30.05%	5,472 $294,000
Q1 2023 May 04, 2023	BUY	$45.86 - $54.45 $36,321 - $43,124	792 Added 11.26%	7,823 $425,000
Q4 2022 Feb 09, 2023	SELL	$38.86 - $48.55 $13,212 - $16,507	-340 Reduced 4.61%	7,031 $340,000
Q4 2022 Feb 06, 2023	BUY	$38.86 - $48.55 $15,777 - $19,711	406 Added 5.83%	7,371 $356,000
Q3 2022 Nov 07, 2022	SELL	$37.22 - $100.5 $4,056 - $10,954	-109 Reduced 1.54%	6,965 $265,000
Q2 2022 Aug 08, 2022	SELL	$48.99 - $57.46 $23,564 - $27,638	-481 Reduced 6.37%	7,074 $354,000
Q1 2022 May 13, 2022	SELL	$48.48 - $53.65 $678 - $751	-14 Reduced 0.18%	7,555 $388,000
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $34,831 - $38,739	740 Added 10.84%	7,569 $379,000
Q3 2021 Dec 08, 2021	SELL	$47.89 - $53.12 $3,926 - $4,355	-82 Reduced 1.19%	6,829 $328,000
Q3 2021 Nov 05, 2021	BUY	$47.89 - $53.12 $37,497 - $41,592	783 Added 12.78%	6,911 $624,000
Q2 2021 Aug 10, 2021	BUY	$49.36 - $54.25 $4,787 - $5,262	97 Added 1.61%	6,128 $323,000
Q4 2020 Feb 11, 2021	SELL	$45.3 - $51.62 $26,002 - $29,629	-574 Reduced 8.69%	6,031 $293,000
Q3 2020 Nov 09, 2020	BUY	$49.47 - $53.77 $8,508 - $9,248	172 Added 2.67%	6,605 $331,000
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $14,675 - $17,955	342 Added 5.61%	6,433 $329,000
Q1 2020 May 12, 2020	BUY	$38.02 - $51.66 $8,592 - $11,675	226 Added 3.85%	6,091 $267,000
Q4 2019 Jan 28, 2020	SELL	$44.25 - $50.86 $79,915 - $91,853	-1,806 Reduced 23.54%	5,865 $296,000
Q3 2019 Oct 22, 2019	SELL	$40.34 - $46.64 $3,469 - $4,011	-86 Reduced 1.11%	7,671 $355,000
Q2 2019 Jul 18, 2019	BUY	$40.43 - $44.3 $12,209 - $13,378	302 Added 4.05%	7,757 $336,000
Q1 2019 May 06, 2019	SELL	$40.83 - $45.43 $304,387 - $338,680	-7,455 Reduced 50.0%	7,455 $329,000
Q1 2019 May 01, 2019	BUY	$40.83 - $45.43 $394,213 - $438,626	9,655 Added 183.73%	14,910 $658,000
Q4 2018 Feb 13, 2019	SELL	$41.48 - $45.59 $12,485 - $13,722	-301 Reduced 5.42%	5,255 $227,000
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $84,600 - $94,836	-2,115 Reduced 27.57%	5,556 $246,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $40,527 - $44,393	1,077 Added 16.33%	7,671 $307,000
Q1 2018 May 18, 2018	BUY	$38.98 - $45.76 $3,781 - $4,438	97 Added 1.49%	6,594 $264,000
Q4 2017 Feb 13, 2018	SELL	$42.86 - $50.61 $12,858 - $15,183	-300 Reduced 4.41%	6,497 $281,000
Q3 2017 Nov 16, 2017	BUY	$47.04 - $50.34 $14,253 - $15,253	303 Added 4.67%	6,797 $340,000
Q2 2017 Aug 15, 2017	BUY	N/A	6,494	6,494 $311,000

Others Institutions Holding SNY

# of Institutions

795

Shares Held

252M

Call Options Held

2.6M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $145B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account